NOVATO, Calif., Jan. 2, 2013 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc., a biotechnology company, today announced that Emil D. Kakkis, M.D., Ph.D, the company’s CEO, will be presenting at the 2013 31st Annual J.P. Morgan Healthcare Conference on Thursday, January 10, 2013 at 8:30am Pacific Time. The conference is being held at the Westin St. Francis Hotel in San Francisco, CA.
